Get the Stockscreener App
144.45
2.50%
-3.7102
After Hours:
144.49
0.0402
+0.03%
Twist Bioscience Corp stock is traded at $144.45, with a volume of 3.36M.
It is down -2.50% in the last 24 hours and up +4.60% over the past month.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
See More
Previous Close:
$148.16
Open:
$138.09
24h Volume:
3.36M
Relative Volume:
0.91
Market Cap:
$9.58B
Revenue:
$409.48M
Net Income/Loss:
$-81.28M
P/E Ratio:
-108.72
EPS:
-1.3286
Net Cash Flow:
$-95.14M
1W Performance:
-5.00%
1M Performance:
+4.60%
6M Performance:
+150.69%
1Y Performance:
+350.84%
1-Day Range:
$130.68
$148.32
1-Week Range:
$130.68
$168.93
52-Week Range:
$23.30
$219.71
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
144.45 | 9.58B | 409.48M | -81.28M | -95.14M | -1.3286 |
VRTX
Vertex Pharmaceuticals Inc
|
508.74 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.35 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.50 | 53.23B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.30 | 42.34B | 5.76B | 514.49M | 1.10B | 4.4813 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-26 | Initiated | Jefferies | Hold |
| Sep-09-26 | Initiated | BWS Financial | Sell |
| Sep-09-26 | Initiated | UBS | Neutral |
| Jul-06-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-15-26 | Initiated | Canaccord Genuity | Buy |
| May-05-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-04-25 | Initiated | Stephens | Overweight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera - GlobeNewswire Inc.
Form 4 Twist Bioscience Corp For: 10 October By Investing.com - Investing.com Canada
A proposed 2,462-share sale at Twist Bioscience (TWST) includes shares to cover an equity-award tax bill. - Stock Titan
Under a trading plan, Twist Bioscience (TWST) CEO sells 4,548 shares on October 5, 2026. - Stock Titan
After a $56.3M sale, Twist Bioscience (TWST) officer Leproust proposes another share sale. - Stock Titan
Twist Bioscience Insiders Sold Shares Worth Over $9.1M - TradingView
After selling 8,057 shares for taxes, Twist Bioscience (TWST) CFO holds 100,576 shares. - Stock Titan
To cover stock-vesting taxes, HR SVP Paula Green sold 10,088 shares of Twist Bioscience (TWST). - Stock Titan
Tax withholding required Twist Bioscience (TWST) COO to sell 25,714 shares - Stock Titan
Twist Bioscience (TWST) officer sells 1,482 shares in a mandatory sale to cover taxes. - Stock Titan
Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity - GlobeNewswire Inc.
Twist Bioscience (NasdaqGS:TWST) Stock Forecast & Analyst Predictions - Simply Wall Street
Certain Stock Options of Twist Bioscience Corporation are subject to a Lock-Up Agreement Ending on 4-OCT-2026. - marketscreener.com
An officer proposes selling 1,482 Twist Bioscience (TWST) shares, including shares to cover taxes. - Stock Titan
An officer's proposed sale at Twist Bioscience (TWST) includes shares to cover an equity-award tax bill. - Stock Titan
An officer’s proposed share sale at Twist Bioscience (TWST) includes stock to cover a tax obligation. - Stock Titan
An officer plans to sell vested shares at Twist Bioscience (TWST), partly to cover a tax obligation. - Stock Titan
An officer proposes selling vested shares at Twist Bioscience (TWST), partly to cover an equity-award tax obligation. - Stock Titan
After a $56.3M sale, a Twist Bioscience (NASDAQ: TWST) officer proposes selling more shares. - Stock Titan
Twist Bioscience SVP Paula Green sells $48,654 in common stock - Investing.com
Twist Bioscience SVP Dennis Cho sells $57,590 in company stock - Investing.com
Under a June trading plan, Twist Bioscience (TWST) CEO Emily M. Leproust sold 5,203 shares in 10 transactions. - Stock Titan
A proposed share sale valued at $922,906 names Emily M. Leproust as the Twist Bioscience (TWST) account holder. - Stock Titan
At $165.4910 a share, Twist Bioscience (TWST) CEO Emily M. Leproust sold stock to cover taxes. - Stock Titan
A required tax-withholding sale: Twist Bioscience (TWST) HR executive Paula Green sells 294 shares. - Stock Titan
Twist Bioscience Corporation (TWST) stock price, news, quote and history - uk.finance.yahoo.com
Twist Bioscience Corporation (TWST) Latest Stock News & HeadlinesYahoo Finance - Yahoo! Finance Canada
Twist Bioscience stock holds near 52-week high after CEO share sale - AD HOC NEWS
After $56M sale, Twist Bioscience (NASDAQ: TWST) insider plans more - Stock Titan
Twist Bioscience (TWST) officer to sell shares to cover tax on equity award - Stock Titan
After $1.8M stock sale, Twist Bioscience (NASDAQ: TWST) insider files to sell more - Stock Titan
Twist Bioscience CEO Emily Leproust sells $56.3m in company stock By Investing.com - Investing.com South Africa
Twist Bioscience(TWST.US) Officer Sells US$56.33 Million in Common Stock - Moomoo
Twist Bioscience (TWST) CEO trades 356K shares at up to $163.60 - Stock Titan
Twist Bioscience CEO Emily Leproust sells $56.3m in company stock - Investing.com
Twist Bioscience CorporationCommon Stock (NQ: TWST - The Chronicle-Journal
Twist Bioscience (NASDAQ: TWST) holder eyes $44.7M stock sale - Stock Titan
New multimillion-dollar stock sale planned at Twist Bioscience (NASDAQ: TWST) - Stock Titan
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery - Business Wire
Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia - investing.com
Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia By Investing.com - Investing.com Australia
Twist Bioscience HR SVP Paula Green Sells Shares to Cover RSU Tax Withholding - Kalkine Media
TWST Initiated Coverage by BWS Financial -- Current Rating: Sell - GuruFocus
BWS Financial initiates Twist Bioscience stock with sell rating - investing.com
TWST Initiates Coverage On UBS -- Rating Set at Neutral with $144 Target - GuruFocus
BWS Financial initiates Twist Bioscience stock with sell rating By Investing.com - Investing.com India
BWS Financial initiates Twist Bioscience stock with sell rating By Investing.com - Investing.com Canada
BWS Financial initiates Twist Bioscience stock with sell rating By Investing.com - Investing.com UK
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference - BioSpace
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference - Business Wire
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Twist Bioscience Corp Stock (TWST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Laponis Adam | Officer |
Oct 09 '26 |
Proposed Sale |
156.30 |
2,462 |
384,823 |
0 |
| Leproust Emily M. | Chief Executive Officer |
Oct 05 '26 |
Sale |
202.15 |
4,548 |
919,374 |
562,760 |
| Leproust Emily M. | Officer |
Oct 05 '26 |
Proposed Sale |
202.15 |
4,548 |
919,374 |
0 |
| WERNER ROBERT F. | Officer |
Oct 02 '26 |
Proposed Sale |
188.88 |
1,482 |
279,926 |
0 |
| Leproust Emily M. | Officer |
Oct 02 '26 |
Proposed Sale |
188.88 |
45,736 |
8,638,789 |
0 |
| Laponis Adam | Officer |
Oct 02 '26 |
Proposed Sale |
188.88 |
8,057 |
1,521,837 |
0 |
| Finn Patrick John | Officer |
Oct 02 '26 |
Proposed Sale |
188.88 |
25,714 |
4,856,958 |
0 |
| Green Paula | Officer |
Oct 02 '26 |
Proposed Sale |
188.88 |
10,088 |
1,905,460 |
0 |
| Cho Dennis | Officer |
Oct 02 '26 |
Proposed Sale |
188.88 |
9,514 |
1,797,040 |
0 |
| Laponis Adam | Chief Financial Officer |
Oct 02 '26 |
Sale |
188.88 |
8,057 |
1,521,838 |
100,576 |
0.20%
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):